Out of 34 LGMD patients, 13 patients showed decreased expression of calpain-3 protein among which 2 patients showed complete loss of calpain-3 protein, whereas 11 patients showed partial loss of calpain-3 protein at its molecular weight location (94 kDa). This evidence concerns the gene CAPN3 and limb-girdle muscular dystrophy.